These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 10516168)
1. Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. Ferrandi M; Salardi S; Tripodi G; Barassi P; Rivera R; Manunta P; Goldshleger R; Ferrari P; Bianchi G; Karlish SJ Am J Physiol; 1999 Oct; 277(4):H1338-49. PubMed ID: 10516168 [TBL] [Abstract][Full Text] [Related]
2. Localization and quantification of the cytoskeleton-associated protein adducin in the kidneys of normal and Milan hypertensive rats. Ness W; Kaiser HW; Drenckhahn D Histochem Cell Biol; 1998 Feb; 109(2):175-80. PubMed ID: 9504778 [TBL] [Abstract][Full Text] [Related]
3. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844 [TBL] [Abstract][Full Text] [Related]
4. alpha-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption. Torielli L; Tivodar S; Montella RC; Iacone R; Padoani G; Tarsini P; Russo O; Sarnataro D; Strazzullo P; Ferrari P; Bianchi G; Zurzolo C Am J Physiol Renal Physiol; 2008 Aug; 295(2):F478-87. PubMed ID: 18524856 [TBL] [Abstract][Full Text] [Related]
5. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Efendiev R; Krmar RT; Ogimoto G; Zwiller J; Tripodi G; Katz AI; Bianchi G; Pedemonte CH; Bertorello AM Circ Res; 2004 Nov; 95(11):1100-8. PubMed ID: 15528469 [TBL] [Abstract][Full Text] [Related]
6. Renal Na,K-ATPase in genetic hypertension. Ferrandi M; Tripodi G; Salardi S; Florio M; Modica R; Barassi P; Parenti P; Shainskaya A; Karlish S; Bianchi G; Ferrari P Hypertension; 1996 Dec; 28(6):1018-25. PubMed ID: 8952591 [TBL] [Abstract][Full Text] [Related]
7. Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium transport caused by a hypertension-linked mutation in human alpha-adducin. Stenström K; Takemori H; Bianchi G; Katz AI; Bertorello AM J Hypertens; 2009 Dec; 27(12):2452-7. PubMed ID: 19657284 [TBL] [Abstract][Full Text] [Related]
8. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. Tripodi G; Valtorta F; Torielli L; Chieregatti E; Salardi S; Trusolino L; Menegon A; Ferrari P; Marchisio PC; Bianchi G J Clin Invest; 1996 Jun; 97(12):2815-22. PubMed ID: 8675693 [TBL] [Abstract][Full Text] [Related]
9. Altered expression of renal aquaporins and α-adducin polymorphisms may contribute to the establishment of salt-sensitive hypertension. Procino G; Romano F; Torielli L; Ferrari P; Bianchi G; Svelto M; Valenti G Am J Hypertens; 2011 Jul; 24(7):822-8. PubMed ID: 21451595 [TBL] [Abstract][Full Text] [Related]
10. alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives. Glorioso N; Filigheddu F; Cusi D; Troffa C; Conti M; Natalizio M; Argiolas G; Barlassina C; Bianchi G Hypertension; 2002 Feb; 39(2 Pt 2):357-62. PubMed ID: 11882573 [TBL] [Abstract][Full Text] [Related]
11. Ouabainlike factor in Milan hypertensive rats. Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560 [TBL] [Abstract][Full Text] [Related]
13. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies. Ferrandi M; Molinari I; Torielli L; Padoani G; Salardi S; Rastaldi MP; Ferrari P; Bianchi G Sci Transl Med; 2010 Nov; 2(59):59ra86. PubMed ID: 21106940 [TBL] [Abstract][Full Text] [Related]
14. Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Manunta P; Cusi D; Barlassina C; Righetti M; Lanzani C; D'Amico M; Buzzi L; Citterio L; Stella P; Rivera R; Bianchi G Kidney Int; 1998 Jun; 53(6):1471-8. PubMed ID: 9607177 [TBL] [Abstract][Full Text] [Related]
15. PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'. Ferrari P; Ferrandi M; Torielli L; Tripodi G; Bianchi G Hypertens Res; 2000 Sep; 23 Suppl():S15-9. PubMed ID: 11016814 [TBL] [Abstract][Full Text] [Related]
16. Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain. Ferrandi M; Molinari I; Rastaldi MP; Ferrari P; Bianchi G; Manunta P J Pharmacol Exp Ther; 2014 Nov; 351(2):278-87. PubMed ID: 25187430 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive compounds that modulate the Na-K pump. Ferrari P; Ferrandi M; Torielli L; Barassi P; Tripodi G; Minotti E; Molinari I; Melloni P; Bianchi G Ann N Y Acad Sci; 2003 Apr; 986():694-701. PubMed ID: 12763920 [TBL] [Abstract][Full Text] [Related]
18. Na+/K+/Cl(-)-cotransporter mediated Rb+ fluxes in membrane vesicles from kidneys of normotensive and hypertensive rats. Ferrandi M; Salardi S; Parenti P; Ferrari P; Bianchi G; Braw R; Karlish SJ Biochim Biophys Acta; 1990 Jan; 1021(1):13-20. PubMed ID: 2294962 [TBL] [Abstract][Full Text] [Related]
19. Na,K-ATPase activity in renal tubule cells from Milan hypertensive rats. Melzi ML; Bertorello A; Fukuda Y; Muldin I; Sereni F; Aperia A Am J Hypertens; 1989 Jul; 2(7):563-6. PubMed ID: 2547401 [TBL] [Abstract][Full Text] [Related]
20. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]